Positron Corporation

POSC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Jun 2025 Mar 2025 Sep 2015 Jun 2015 Mar 2015 Dec 2014
Operating Activities
Net Income $-821.4K $-1.4M $-1.2M $-1.5M $-255.0K $-375.0K $-554.0K $86.0K
Depreciation & Amortization — — — — $32.0K $26.0K $40.0K $40.0K
Depreciation $9.6K $9.6K $4.7K $4.7K $135 $-775 $1.8K —
Amortization — — — — — — — —
Stock-Based Compensation $0 $5.0M — — $0 $0 $159.0K $89.0K
Net Cash from Operating Activities $-1.0M $-788.7K $-886.4K $-1.4M $-48.0K $-161.0K $-336.0K $-532.0K
Investing Activities
Capital Expenditures — — — — $0 $0 $0 $1.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $0 $-325.0K $0 $5.3M — — — —
Net Change in Cash $-1.0M $-1.1M $-886.4K $3.8M $-61.0K $10.0K $-129.0K $-579.0K
Free Cash Flow — — — — $-48.0K $-161.0K $-336.0K $-533.0K
← Newer Page 1 of 3 Older →